Thrombosis Research, 1879-2472

Tidskrift

Fler filtreringsmöjligheter
  1. 1978
  2. Purification of F.VIII:C by antigen-antibody chromatography

    R. Ljung & Lars Holmberg, 1978, I: Thrombosis Research. 12, 4, s. 667-675 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 1981
  4. F VIII:CAg in Haemophilia A. A comparison between IRMA:s using haemophilic and spontaneous antibodies

    R Ljung & Lars Holmberg, 1981 okt 1, I: Thrombosis Research. 24, 1-2, s. 45-50 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 1983
  6. The effects of plasmin and protein Ca on factor VIII:C and VIII:CAg

    Lars Holmberg, R Ljung & Inga Marie Nilsson, 1983 jul 1, I: Thrombosis Research. 31, 1, s. 41-50 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 1987
  8. Plasma lipolytic activity after subcutaneous administration of heparin and a low molecular weight heparin fragment

    E Persson, J Nordenstrom, L Hagenfeldt & Peter Nilsson-Ehle, 1987, I: Thrombosis Research. 46, 5, s. 697-704

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 1989
  10. Influence of a low molecular weight heparin on the inhibition of factor Xa and thrombin in hip surgery

    Thomas Mätzsch, David Bergqvist, Hans Fredin, Ulla Hedner & Per Ostergaard, 1989, I: Thrombosis Research. 56, 4, s. 559-564

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 1991
  12. Pharmacokinetics of a low molecular weight heparin, logiparin, after intravenous and subcutaneous administration to healthy volunteers

    P C Pedersen, P B Ostergaard, U Hedner, D Bergqvist & Thomas Mätzsch, 1991, I: Thrombosis Research. 61, 5-6, s. 477-487

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 1992
  14. Effect on primary haemostasis of prophylactic regimens of low molecular weight heparin, unfractionated heparin, dextran and their combinations. An animal experimental study

    Jan Holst, Bengt Lindblad, Thomas Mätzsch & David Bergqvist, 1992, I: Thrombosis Research. 65, 4-5, s. 651-656

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 1993
  16. Effect of unfragmented heparin alone and in combination with dextran on experimental venous thrombosis in rabbits

    Stefan E Matthiasson, Bengt Lindblad, Thomas Mätzsch & David Bergqvist, 1993, I: Thrombosis Research. 72, 2, s. 169-172

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Tissue factor pathway inhibitor (TFPI) and its response to heparin in patients with spontaneous deep vein thrombosis

    Jan Holst, Bengt Lindblad, Eva Wedeberg, David Bergqvist, Ole Nordfang, Per B. Østergaard & Ulla Hedner, 1993 dec 1, I: Thrombosis Research. 72, 5, s. 467-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 1995
  19. Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects

    Naomi Clyne, Bo Berglund & Nils Egberg, 1995 jul 1, I: Thrombosis Research. 79, 1, s. 125-129 5 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Binding of prothrombin to chyle chylomicrons: effects of temperatuure and calcium ions, and role of surface phospholipids.

    Ning Xu, Ann-Kristin Öhlin, Li Zhou & Åke Nilsson, 1995 okt 1, I: Thrombosis Research. 80, 1, s. 35-46

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Effects of hemodialysis and longterm erythropoietin treatment on protein C, and on free and total protein S

    Naomi Clyne, Nils Egberg & Lars Eric Lins, 1995 okt 15, I: Thrombosis Research. 80, 2, s. 161-168 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. 1996
  23. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.

    Bengt Zöller, L Norlund, Håkan Leksell, Jan-Erik Nilsson, Henning von Schenck, Ulf Rosén, J O Jepsson & Björn Dahlbäck, 1996, I: Thrombosis Research. 83, 6, s. 475-477 3 s.

    Forskningsoutput: TidskriftsbidragLetter

  24. Catabolism of prothrombin-chylomicron complexes in vivo in the rat

    Ning Xu, Li Zhou, Ann-Kristin Öhlin & Åke Nilsson, 1996 jan 15, I: Thrombosis Research. 81, 2, s. 203-212 8822135.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor

    Jan Holst, Bengt Lindblad, Gertie Westerlund, Claus Bregengaard, Mirella Ezban, Per B. ØStergaard, Ole Nordfang & Ulla Hedner, 1996 feb 15, I: Thrombosis Research. 81, 4, s. 461-470

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. 1997
  27. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man

    Jan Holst, Bengt Lindblad, David Bergqvist, Ulla Hedner, Ole Nordfang & Per Ostergaard, 1997, I: Thrombosis Research. 86, 4, s. 343-348

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Activated protein C resistance caused by a common factor V mutation has a single origin

    Bengt Zöller, Andreas Hillarp & Björn Dahlbäck, 1997 feb 1, I: Thrombosis Research. 85, 3, s. 237-43 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 1999
  30. Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin

    Johan Holm, Andreas Hillarp, Leif RW Erhardt & Erik Berntorp, 1999, I: Thrombosis Research. 96, 3, s. 205-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. 2000
  32. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters

    Anna Jerkeman, Jan Astermark, Ulla Hedner, Stefan Lethagen, Carl-Gustav Olsson & Erik Berntorp, 2000, I: Thrombosis Research. 98, 6, s. 467-471

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. 2001
  34. Anti- and procoagulant activities in factor VII-deficient subjects

    Jan Astermark, L Tengborn, Ulla Hedner & Erik Berntorp, 2001, I: Thrombosis Research. 101, 6, s. 435-440

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2002
  36. Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

    K Wahlander, L Lapidus, Carl-Gustav Olsson, A Thuresson, UG Eriksson, G Larson & H Eriksson, 2002, I: Thrombosis Research. 107, 3-4, s. 93-99

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 2003
  38. Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.

    Andreas Hillarp, Barbro Palmqvist, Stefan Lethagen, Bruno O Villoutreix & Ingrid Mattiasson, 2003, I: Thrombosis Research. 112, 5-6, s. 275-283

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. 2004
  40. Genetic variation in the human thrombomodulin promoter locus and prognosis after acute coronary syndrome.

    Ann-Kristin Öhlin, Johan Holm & Andreas Hillarp, 2004, I: Thrombosis Research. 113, 5, s. 319-326

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 2005
  42. 2006
  43. Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex.

    Pallonji Bhiladvala, Karin Strandberg, Johan Stenflo & Johan Holm, 2006, I: Thrombosis Research. 118, Aug 10, s. 213-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. The need for prophylaxis in von Willebrand's disease and other coagulation disorders

    A Street & Erik Berntorp, 2006, I: Thrombosis Research. 118, s. S1-S2

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  45. The von Willebrand Disease Prophylaxis Network (vWD PN): Exploring a treatment concept.

    Erik Berntorp & Thomas Abshire, 2006, I: Thrombosis Research. 18, s. S19-S22

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2007
  47. Antithrombotic and anticoagulant effects of wild type and Gla-domain mutated human activated protein C in rats.

    Karl Malm, Björn Arnljots, Ing-Marie Persson & Björn Dahlbäck, 2007, I: Thrombosis Research. 120, 4, s. 531-539

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcers

    Majid Kalani, Angela Silveira, Margareta Blomback, Jan Apelqvist, Bjorn Eliasson, Jan W. Eriksson, Bengt Fagrell, Ole Torffvit, Anders Hamsten & Gun Jorneskog, 2007, I: Thrombosis Research. 120, 5, s. 653-661

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Erik von Willebrand.

    Erik Berntorp, 2007, I: Thrombosis Research. 120, s. S3-S4

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. The APC-PCI complex concentration predicts outcome of aortic surgery.

    Gunnar Nilsson, Karin Strandberg, Jan Astermark, Einar Vernersson, Johan Stenflo & Erik Berntorp, 2007, I: Thrombosis Research. 120, s. 237-244

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Von Willebrand: The scientist, the disease, the factor, and the treatment

    Erik Berntorp & David Lillicrap, 2007, I: Thrombosis Research. 120, s. S1-S1

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  52. 2008
  53. 2009
  54. Clinical probability assessment and D-dimer determination in patients with suspected deep vein thrombosis, a prospective multicenter management study.

    J L Elf, Karin Strandberg, Cecilia Nilsson & P J Svensson, 2009, I: Thrombosis Research. May 29, s. 612-616

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Haemate P/Humate-P: a systematic review.

    Erik Berntorp, 2009, I: Thrombosis Research. 124 Suppl 1, Nov, s. S11-S14

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Increased thrombin generation in women with a history of preeclampsia

    R. Rafik Hamad, J. Curvers, Erik Berntorp, M. J. Eriksson & K. Bremme, 2009, I: Thrombosis Research. 123, 4, s. 580-586

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. Thrombin generation after emergency contraception

    M. van Rooijen, Erik Berntorp & K. Bremme, 2009, I: Thrombosis Research. 123, s. S152-S152

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  58. 2010
  59. A Cost-effectiveness Analysis of Diagnostic Algorithms of Deep Vein Thrombosis at the Emergency Department.

    Jenny M Norlin, Johan Elf, Peter Svensson & Katarina Steen Carlsson, 2010, I: Thrombosis Research. Jul 1, s. 195-199

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. Anti-prothrombin antibodies are associated with thrombosis in children.

    Olof Rask, Andreas Hillarp, Erik Berntorp & Rolf Ljung, 2010, I: Thrombosis Research. 125, s. 19-24

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. Coagulation activation and ultrasound characteristics in patients with carotid artery disease.

    Tilo Kölbel, Isabel Goncalves, Nuno Dias, Karin Strandberg, Stefan Acosta & Anders Gottsäter, 2010, I: Thrombosis Research. 125, s. 171-177

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. History of rFVIIa therapy.

    Ulla Hedner, 2010, I: Thrombosis Research. 125 Suppl 1, s. S4-S6

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Retrospective analysis of coagulation parameters at epidural anaesthesia catheter withdrawal after esophageal resection

    P. A. Anveden, L. Preutz, Åsa Rudin, Per Flisberg, E. Eldh & Ulf Schött, 2010, I: Thrombosis Research. 125, Suppl. 2, s. S177-S178

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

  64. Tissue factor phosphorylation requires protease activated receptor-2 expression: Correlation with the prognosis of human breast cancer

    Lisa Rydén, Dorthe Grabau, F. Schaffner, P. -E. Jonsson, W. Ruf & Mattias Belting, 2010, I: Thrombosis Research. 125, s. S164-S164

    Forskningsoutput: TidskriftsbidragPublicerat konferensabstract

Föregående 1 2 3 Nästa